# Curaleaf Holdings, Inc.: financial statements, quarterly

CURLF · OTC · CIK 1756770 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/curlf.md) · [Financials](/companies/curlf/financials.md) · [Filings](/companies/curlf/filings.md) · [Insiders](/companies/curlf/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/curlf/financials.md?period=annual).

## Income statement

| Line item | Unit | period not labelled (2019-03-31) | period not labelled (2020-03-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | period not labelled (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | [311](/filings/0001756770-26-000075.md) | not reported | [340](/filings/0001756770-26-000075.md) |
| Cost of revenue | $m | not reported | not reported | not reported | [158](/filings/0001756770-26-000075.md) | not reported | [170](/filings/0001756770-26-000075.md) |
| Gross profit | $m | not reported | not reported | not reported | [153](/filings/0001756770-26-000075.md) | not reported | [170](/filings/0001756770-26-000075.md) |
| Selling, general and administrative | $m | not reported | not reported | not reported | [111](/filings/0001756770-26-000075.md) | not reported | [132](/filings/0001756770-26-000075.md) |
| Operating income | $m | not reported | not reported | not reported | [6.2](/filings/0001756770-26-000075.md) | not reported | [4.2](/filings/0001756770-26-000075.md) |
| Income tax | $m | not reported | not reported | not reported | [31.8](/filings/0001756770-26-000075.md) | not reported | [(38.8)](/filings/0001756770-26-000075.md) |
| Net income | $m | [(26.6)](/filings/0001558370-21-005147.md) | [(35.3)](/filings/0001558370-21-005147.md) | [(61.1)](/filings/0001756770-26-000075.md) | [(53.2)](/filings/0001756770-26-000075.md) | [69.8](/filings/0001756770-26-000075.md) | [12.5](/filings/0001756770-26-000075.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | [(0.26)](/filings/0001756770-26-000075.md) | not reported | [0.05](/filings/0001756770-26-000075.md) |
| Basic EPS | $ per share | not reported | not reported | not reported | [(0.26)](/filings/0001756770-26-000075.md) | not reported | [0.05](/filings/0001756770-26-000075.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: ifrs-full:ProfitLossAttributableToOwnersOfParent, us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | period not labelled (2018-12-31) | period not labelled (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | period not labelled (2025-03-31) | period not labelled (2025-06-30) | FY2025 (2025-12-31) | period not labelled (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [267](/filings/0001558370-21-005147.md) | [42.3](/filings/0001558370-23-007553.md) | [73.5](/filings/0001558370-23-007553.md) | [299](/filings/0001558370-23-007893.md) | [163](/filings/0001558370-23-007893.md) | not reported | not reported | not reported | [87.7](/filings/0001756770-26-000075.md) | [89.2](/filings/0001756770-26-000075.md) | not reported | [94.6](/filings/0001756770-26-000075.md) |
| Current assets | $m | not reported | [150](/filings/0001558370-21-005147.md) | [418](/filings/0001558370-23-007553.md) | [727](/filings/0001558370-23-007893.md) | [652](/filings/0001756770-24-000016.md) | [419](/filings/0001756770-25-000008.md) | [434](/filings/0001756770-26-000019.md) | not reported | not reported | [449](/filings/0001756770-26-000075.md) | not reported | [468](/filings/0001756770-26-000075.md) |
| Total assets | $m | not reported | [737](/filings/0001558370-21-005147.md) | [2,366](/filings/0001558370-23-007553.md) | [3,105](/filings/0001558370-23-007893.md) | [3,415](/filings/0001756770-24-000016.md) | [3,097](/filings/0001756770-25-000008.md) | [2,950](/filings/0001756770-26-000019.md) | not reported | not reported | [2,845](/filings/0001756770-26-000075.md) | not reported | [2,814](/filings/0001756770-26-000075.md) |
| Current liabilities | $m | not reported | [106](/filings/0001558370-21-005147.md) | [220](/filings/0001558370-23-007553.md) | [316](/filings/0001558370-23-007893.md) | [497](/filings/0001756770-24-000016.md) | [494](/filings/0001756770-25-000008.md) | [388](/filings/0001756770-26-000019.md) | not reported | not reported | [294](/filings/0001756770-26-000075.md) | not reported | [307](/filings/0001756770-26-000075.md) |
| Total liabilities | $m | not reported | [333](/filings/0001558370-21-005147.md) | [985](/filings/0001558370-23-007553.md) | [1,440](/filings/0001558370-23-007893.md) | [2,014](/filings/0001756770-24-000016.md) | [1,925](/filings/0001756770-25-000008.md) | [1,956](/filings/0001756770-26-000019.md) | not reported | not reported | [2,005](/filings/0001756770-26-000075.md) | not reported | [1,947](/filings/0001756770-26-000075.md) |
| Long-term debt | $m | not reported | not reported | not reported | [458](/filings/0001558370-23-007893.md) | [571](/filings/0001756770-24-000016.md) | [548](/filings/0001756770-25-000008.md) | [467](/filings/0001756770-26-000019.md) | not reported | not reported | [513](/filings/0001756770-26-000075.md) | not reported | [571](/filings/0001756770-26-000075.md) |
| Current portion of debt | $m | not reported | not reported | not reported | [2.0](/filings/0001558370-23-007893.md) | [51.9](/filings/0001756770-24-000016.md) | [39.5](/filings/0001756770-25-000008.md) | [102](/filings/0001756770-26-000019.md) | not reported | not reported | [35.7](/filings/0001756770-26-000075.md) | not reported | [41.0](/filings/0001756770-26-000075.md) |
| Shareholders' equity | $m | [436](/filings/0001558370-21-005147.md) | [409](/filings/0001558370-21-005147.md) | [1,277](/filings/0001558370-23-007893.md) | [1,546](/filings/0001756770-24-000016.md) | [1,280](/filings/0001756770-25-000008.md) | [1,051](/filings/0001756770-26-000019.md) | [861](/filings/0001756770-26-000075.md) | [814](/filings/0001756770-26-000075.md) | [871](/filings/0001756770-26-000075.md) | [756](/filings/0001756770-26-000075.md) | [821](/filings/0001756770-26-000075.md) | [867](/filings/0001756770-26-000075.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents, us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: ifrs-full:CurrentAssets, us-gaap:AssetsCurrent
- Total assets: ifrs-full:Assets, us-gaap:Assets
- Current liabilities: ifrs-full:CurrentLiabilities, us-gaap:LiabilitiesCurrent
- Total liabilities: ifrs-full:Liabilities, us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: ifrs-full:Equity, ifrs-full:EquityAttributableToOwnersOfParent, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest, us-gaap:StockholdersEquity

## Shares

| Line item | Unit | period not labelled (2025-06-30) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [252](/filings/0001756770-26-000075.md) | [271](/filings/0001756770-26-000075.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 623,520,125 at 2022-12-31, from the cover of the [40-F/A filed 2023-05-03](/filings/0001558370-23-007893.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:47 ET. No prices; not investment advice.